Volume 26, Number 5—May 2020
Dispatch
Species Distribution and Isolation Frequency of Nontuberculous Mycobacteria, Uruguay
Gonzalo Greif
, Cecilia Coitinho, Jakko van Ingen, and Carlos Robello
, Cecilia Coitinho, Jakko van Ingen, and Carlos Robello
Table 1
Specimen sources for isolation of nontuberculous mycobacteria, Uruguay*
| Specimen source | No. (%) |
|---|---|
| Pulmonary | |
| Sputum | 170 (66.6) |
| Bronchoalveolar lavage | 18 (7.0) |
| Bronchoalveolar secretions† | 8 (3.1) |
| Lung biopsy | 6 (2.3) |
| Pleural fluid | 3 (1.2) |
| Ear, nose, throat aspirate | 2 (0.8) |
| Puncture fluid | 3 (1.2) |
| Total |
210 (82.3) |
| Extrapulmonary | |
| Blood culture | 15 (5.9) |
| Myelocyte culture | 9 (3.5) |
| Skin or soft tissue abscess | 4 (1.6) |
| Urine | 1 (0.4) |
| Feces | 2 (0.8) |
| Gastric lavage | 1 (0.4) |
| Ganglion biopsy | 3 (1.2) |
| Ascites fluid | 3 (1.2) |
| Total |
38 (14.9) |
| Multiple isolation sources‡ | 3 (1.2) |
| Missing data |
4 (1.6) |
| *The data include isolates from the same patient over time. †Includes tracheal aspirations. ‡Includes pulmonary and nonpulmonary samples of the same patient. | |
Page created: April 16, 2020
Page updated: April 16, 2020
Page reviewed: April 16, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.